| |
| |
|
| Insider
Information: |
Alleva Lawrence M |
| Relationship: |
Director |
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
87,376 |
|
|
Indirect Shares
|
86,970 |
|
|
| Direct
Value |
$118,843 |
|
|
|
Indirect Value
|
$87,091 |
|
|
| Total
Shares |
174,346 |
|
|
| Total
Value |
$205,935 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
6
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
-6.0
|
0.0
|
| Percentage
Gain/Loss : |
 -43.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Tesaro, Inc. |
TSRO |
Director |
2019-01-22 |
0 |
2012-07-03 |
0 |
Premium* |
|
|
Synlogic Inc |
SYBX |
Director |
2015-10-05 |
0 |
2015-10-06 |
4,025 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
Director |
2021-06-01 |
70,584 |
2021-06-01 |
72,780 |
Premium* |
|
|
Galera Therapeutics, Inc. |
GRTX |
Director |
2022-07-18 |
2,325 |
2022-07-18 |
8,045 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
Director |
2023-06-08 |
14,467 |
2023-06-08 |
2,120 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2023-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
14,467 |
14,467 |
0 |
- |
|
| GRTX |
Galera Therapeutics, Inc. |
Director |
– • – |
2022-07-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,000 |
2,325 |
0 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
Director |
– • – |
2021-06-01 |
4 |
B |
$0.79 |
$9,954 |
I/I |
12,600 |
12,600 |
2.1 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2021-06-01 |
4 |
B |
$14.38 |
$14,883 |
I/I |
1,035 |
2,120 |
2.1 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
Director |
– • – |
2021-06-01 |
4 |
B |
$8.59 |
$34,741 |
I/I |
4,045 |
4,045 |
2.1 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
Director |
– • – |
2020-11-13 |
4 |
B |
$10.22 |
$23,771 |
D/D |
2,325 |
6,325 |
2.39 |
% |
|
| ADAP |
Adaptimmune Therapeutics ... |
Director |
– • – |
2020-06-09 |
4 |
B |
$1.89 |
$24,381 |
I/I |
12,900 |
12,900 |
2.1 |
% |
|
| MRSN |
Mersana Therapeutics, Inc... |
Director |
– • – |
2020-06-01 |
4 |
B |
$22.94 |
$24,901 |
D/D |
1,085 |
1,085 |
2.39 |
% |
|
| GRTX |
Galera Therapeutics, Inc. |
Director |
– • – |
2019-12-13 |
4 |
B |
$9.78 |
$39,139 |
D/D |
4,000 |
4,000 |
2.39 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2019-01-22 |
4 |
D |
$75.00 |
$2,242,650 |
D/D |
(29,902) |
0 |
0 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
Director |
– • – |
2018-12-17 |
4 |
B |
$0.84 |
$39,715 |
I/I |
47,280 |
47,280 |
2.1 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2018-06-12 |
4 |
AS |
$42.62 |
$307,920 |
D/D |
(7,142) |
29,902 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2018-06-12 |
4 |
OE |
$6.62 |
$47,244 |
D/D |
7,142 |
37,044 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,599 |
29,902 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2017-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
469 |
28,303 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2016-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,480 |
27,834 |
0 |
- |
|
| ADAP |
Adaptimmune Therapeutics ... |
Director |
– • – |
2016-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
70,584 |
|
- |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2015-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
207 |
4,025 |
0 |
- |
|
| SYBX |
Synlogic Inc |
Director |
– • – |
2015-10-05 |
4 |
A |
$0.00 |
$0 |
I/I |
3,818 |
3,818 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2015-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,069 |
26,354 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2014-09-29 |
4 |
B |
$26.17 |
$28,787 |
D/D |
1,100 |
25,285 |
2.39 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2014-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
2,522 |
24,185 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-07-31 |
4 |
B |
$34.33 |
$49,744 |
D/D |
1,449 |
21,663 |
2.39 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
1,114 |
20,214 |
0 |
- |
|
| TSRO |
Tesaro, Inc. |
Director |
– • – |
2013-04-30 |
4 |
B |
$28.10 |
$29,505 |
D/D |
1,050 |
19,100 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
